Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Carbone

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
Expert Opinion on Therapeutic Targets|January 18, 2022
An update on novel pharmacological agents for primary sclerosing cholangitisCamilla Gallo, Bright Oworae Howardson, Laura Cristoferi, et al.
Hepatology Communications|September 10, 2019
A National Hospital-Based Study of Hospitalized Patients With Primary Biliary CholangitisValerio Manno, Alessio Gerussi, Marco Carbone, et al.
Journal of Hepatology|May 1, 2013
The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective studyMarco Carbone, Sally Bufton, Andrea Monaco, et al.
Minerva Gastroenterology|December 10, 2020
Risk stratification in primary sclerosing cholangitisGiacomo Mulinacci, Laura Cristoferi, Andrea Palermo, et al.
Autoimmunity Reviews|July 10, 2016
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approachHani S Mousa, Marco Carbone, Federica Malinverno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trialPietro Invernizzi, Marco Carbone, David Jones, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2019
Letter: histology is relevant for risk stratification in primary biliary cholangitisMarco Carbone, Daphne D'Amato, Gideon M Hirschfield, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 12, 2022
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injuryAna Lleo, Nora Cazzagon, Cristina Rigamonti, et al.
The Journal of Pediatrics|July 30, 2020
Epiphyseal Cleft: A Misleading Radiologic FindingMatteo Trevisan, Pierandrea Elefante, Elisabetta Cattaruzzi, et al.
Children (Basel, Switzerland)|August 26, 2023
Study Confirms Safety and Effectiveness of Intra-Articular Glucocorticoids for Painful Hip Dislocation in Children and Young Adults with Neurologic ImpairmentSimone Benvenuto, Egidio Barbi, Silvia Boaretto, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
Expert Opinion on Therapeutic Targets|January 18, 2022
An update on novel pharmacological agents for primary sclerosing cholangitisCamilla Gallo, Bright Oworae Howardson, Laura Cristoferi, et al.
Hepatology Communications|September 10, 2019
A National Hospital-Based Study of Hospitalized Patients With Primary Biliary CholangitisValerio Manno, Alessio Gerussi, Marco Carbone, et al.
Journal of Hepatology|May 1, 2013
The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective studyMarco Carbone, Sally Bufton, Andrea Monaco, et al.
Minerva Gastroenterology|December 10, 2020
Risk stratification in primary sclerosing cholangitisGiacomo Mulinacci, Laura Cristoferi, Andrea Palermo, et al.
Autoimmunity Reviews|July 10, 2016
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approachHani S Mousa, Marco Carbone, Federica Malinverno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trialPietro Invernizzi, Marco Carbone, David Jones, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2019
Letter: histology is relevant for risk stratification in primary biliary cholangitisMarco Carbone, Daphne D'Amato, Gideon M Hirschfield, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 12, 2022
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injuryAna Lleo, Nora Cazzagon, Cristina Rigamonti, et al.
The Journal of Pediatrics|July 30, 2020
Epiphyseal Cleft: A Misleading Radiologic FindingMatteo Trevisan, Pierandrea Elefante, Elisabetta Cattaruzzi, et al.
Children (Basel, Switzerland)|August 26, 2023
Study Confirms Safety and Effectiveness of Intra-Articular Glucocorticoids for Painful Hip Dislocation in Children and Young Adults with Neurologic ImpairmentSimone Benvenuto, Egidio Barbi, Silvia Boaretto, et al.
Pageof 19